IRIS
CORRADO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.836
NA - Nord America 6.039
AS - Asia 3.488
SA - Sud America 1.109
AF - Africa 102
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.901
RU - Federazione Russa 4.043
SG - Singapore 1.493
CN - Cina 1.088
BR - Brasile 946
IE - Irlanda 879
SE - Svezia 823
DE - Germania 407
IT - Italia 360
HK - Hong Kong 346
UA - Ucraina 288
FR - Francia 282
PL - Polonia 212
VN - Vietnam 188
GB - Regno Unito 186
FI - Finlandia 181
IN - India 102
CA - Canada 64
AR - Argentina 62
MX - Messico 47
BE - Belgio 46
BD - Bangladesh 39
JP - Giappone 31
TR - Turchia 31
ZA - Sudafrica 30
NL - Olanda 28
IQ - Iraq 26
MA - Marocco 25
EC - Ecuador 24
ES - Italia 23
PK - Pakistan 22
UZ - Uzbekistan 17
AT - Austria 16
VE - Venezuela 16
CO - Colombia 14
ID - Indonesia 14
CZ - Repubblica Ceca 13
UY - Uruguay 12
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
PE - Perù 10
KE - Kenya 9
AL - Albania 8
JM - Giamaica 8
PH - Filippine 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
AU - Australia 7
EG - Egitto 7
IR - Iran 7
KZ - Kazakistan 7
BO - Bolivia 6
CI - Costa d'Avorio 6
CL - Cile 6
JO - Giordania 6
LT - Lituania 6
DO - Repubblica Dominicana 5
GY - Guiana 5
HN - Honduras 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KH - Cambogia 3
KR - Corea 3
LV - Lettonia 3
NG - Nigeria 3
SN - Senegal 3
TH - Thailandia 3
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
Totale 18.577
Salva come PNG Salva come JPEG
Città #
Moscow 1.065
Ashburn 1.010
Singapore 882
Dublin 878
Chandler 643
Jacksonville 575
Dallas 529
Nyköping 431
Beijing 394
Hong Kong 346
San Jose 310
Warsaw 193
Boardman 160
Ann Arbor 157
The Dalles 157
Los Angeles 151
Lauterbourg 131
Princeton 129
Cambridge 127
Messina 120
Munich 111
Medford 110
Dearborn 106
Des Moines 101
São Paulo 81
Ho Chi Minh City 67
Buffalo 62
Woodbridge 61
New York 53
Brussels 46
Shenyang 40
Tianjin 40
Jinan 39
Catania 37
Frankfurt am Main 37
Turku 37
Santa Clara 36
Wilmington 36
Bremen 35
Hanoi 33
Guangzhou 31
Hyderabad 29
Orem 27
Tokyo 27
Belo Horizonte 26
Düsseldorf 26
Hebei 25
Lancaster 25
Montreal 25
Nanjing 25
Chennai 24
Houston 24
London 24
Redondo Beach 24
Zhengzhou 24
Helsinki 23
Rio de Janeiro 23
Brooklyn 21
Denver 21
San Mateo 21
Seattle 20
Washington 20
Stockholm 19
Shanghai 18
Amsterdam 17
Curitiba 17
Porto Alegre 17
Johannesburg 16
Boston 15
Hangzhou 15
Ningbo 15
Atlanta 14
Brasília 14
Haikou 14
Manchester 14
Tashkent 14
Chicago 13
Mexico City 13
San Francisco 13
Sorocaba 13
Auburn Hills 12
Baghdad 12
Dong Ket 12
Ottawa 12
Taizhou 12
Mumbai 11
Pune 11
Shenzhen 11
Da Nang 10
Toronto 10
Wroclaw 10
Baku 9
Campinas 9
Guayaquil 9
Jakarta 9
Milan 9
Nanchang 9
Phoenix 9
Poplar 9
Quito 9
Totale 10.566
Salva come PNG Salva come JPEG
Nome #
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 243
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 232
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 226
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 215
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 214
Italian risk factor-based screening for gestational diabetes. 207
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 207
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 205
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 202
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 202
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis 197
A 45,MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y EUCHROMATIN ONTO CHROMOSOME 1 196
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 196
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 196
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 191
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 188
A 45,X MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y- EUCHROMATIN ONTO CHROMOSOME-1 186
Myo-inositol may prevent gestational diabetes in PCOS women 186
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 185
Abortività spontanea ed età materna avanzata. 182
Effects of myo-inositol on glucose variability in women with gestational diabetes 181
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 180
Cardiovascular effects of raloxifene hydrochloride 179
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 178
C-reactive protein as an early predictor of gestational diabetes mellitus 175
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 173
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 172
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 170
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 169
Intravaginal vs. intracervical PGE(2) gel first application for labor induction 168
Glucose Tolerance and insulin secretion in pregnancy 167
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 167
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 167
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 167
"Anticorpi antifosfolipidi ed aborto ricorrente". 165
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 165
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
Screening for gestational diabetes in Sicily. 163
Celiac disease in pregnancy: not always a relapse 163
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 163
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 161
Compliance with hormone replacement therapy in postmenopausal Sicilian women 161
Cardiovascular effects of the phytoestrogen genistein 161
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 160
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 160
PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA DURING ASPIRIN TREATMENT 159
A randomised trial of progesterone prophylaxis after midtrimester amniocentesis 158
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 157
Maternal serum PAPP-A as an early marker of obstetric complications? 157
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 155
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 155
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 153
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 153
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 153
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 150
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 150
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 149
Effects of a phyto complex on well-being of climacteric women 149
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 148
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 148
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 148
Diagnosis of gestational diabetes mellitus: italian perspectives on risk factor based screening 148
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 147
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 147
Midtrimester amniotic fluid adiponectin in normal pregnancy. 147
Differences in body composition between post-menopausal women with and without dyslipidemia. 147
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 143
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 138
Pregnancy outcome following mid-trimester amniocentesis 138
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 138
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 136
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 136
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 135
Diagnosis of celiac disease in pregnancy and puerperium: think about it 134
Screening for gestational diabetes in Sicily 134
La disfunzione diastolica nel diabete gestazionale 134
Modalità di prelievo in corso d'amniocentesi ed outcome ostetrico 134
A 45,X male with molecular evidence of a translocation of Y euchromatin onto chromosome 1 133
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 133
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 132
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 132
Spontaneous abortion and advanced maternal age 129
Sindrome mano-piede-utero. Descrizione di un caso ad ereditarietà autosomica recessiva. 128
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 128
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 127
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 126
Hand-foot-uterus syndrome: a report of a case with recessive autosomal inhereditance 126
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 125
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 125
Intolleranza glucidica e disordini ipertensivi in gravidanza. 124
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 123
TESTICULAR REGRESSION SYNDROME - A CASE-REPORT 121
Role of urocortin in pregnancy: an update and future perspectives 121
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 118
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 118
La disfunzione diastolica nel diabete gestazionale 117
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 115
Inflammatory markers in women with a recent history of gestational diabetes mellitus 110
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 110
I LIVELLI SIERICI DI NGAL NEL PRIMO TRIMESTRE DELLA GRAVIDANZA SONO PREDITTIVI DELL’INSORGENZA DI DIABETE GESTAZIONALE. 105
Totale 15.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 0 0 0 0 0 72 38
2021/2022979 11 155 18 28 35 11 60 37 24 239 105 256
2022/20232.621 181 260 140 171 218 263 15 155 1.094 15 82 27
2023/2024703 54 96 46 97 64 113 16 21 7 46 7 136
2024/20252.796 44 34 52 196 127 114 43 583 674 200 283 446
2025/20268.794 504 554 550 597 680 1.909 1.066 1.205 1.265 371 93 0
Totale 18.779